ACT NOW! Protect our Right to Confidentiality
We are still in the process of pushing back against legislation to weaken the protections of the federal law (42 USC §290dd-2) that support the regulations for the Confidentiality of Substance Use Disorder Records, 42 CFR Part 2 (collectively known as “Part 2”). Right now, H.R. 3545, (the “Overdose Prevention and Patient Safety Act”) still remains as the major effort to eliminate Part 2’s protections of requiring patient consent for disclosures of substance use disorder information for treatment purposes. Unfortunately, H.R. 3545 is very much in play in the House Energy and Commerce Committee, and those in favor of rolling back confidentiality protections to a HIPAA standard have submitted their views to the House Energy and Commerce Committee.
Now it is our turn. As a supporter of patient confidentiality and/or the Consensus Principles of the Campaign to Protect Patient Privacy Rights, we need each organization to write a letter in support of patient confidentiality and consent. Your organizational and individual letters are needed as soon as possible.
This template can assist you in writing your letters of support of not rolling back patient consent. In addition, the template letter explains there are two other bills that would help to protect confidentiality and facilitate care coordination, instead of H.R. 3545: (the Senate’s bipartisan ‘‘Opioid Crisis Response Act of 2018,” and H.R. 3331 – Introduced by Representative Lynn Jenkins and co-sponsored by Representative Doris Matsui).
Your correspondence should be e-mailed to the Minority House Energy and Commerce Committee staffer, Waverly Gordon, (Waverly.Gordon@mail.house.gov) and the Majority House Energy and Commerce Committee staffer, Kristen Shatynski (Kristen.Shatynski@mail.house.gov).
The letters should be addressed to:
Representative Greg Walden, Chairman, U.S. House of Representatives, Energy and Commerce Committee, 2185 Rayburn House Office Building, Washington, DC 20515
Representative Frank Pallone, Jr., Ranking Member, U.S. House of Representatives, Energy and Commerce Committee, 237 Cannon House Office Building, Washington, DC 20515.